Private flu vaccine stocks running low as cases rise
Pharmaceutical companies, including major manufacturers like Sanofi and GlaxoSmithKline, have indicated that production delays and increased demand have contributed to the shortages. Experts warn that these low stocks could hinder efforts to control the spread of the virus, particularly among vulnerable populations such as the elderly and those with pre-existing health conditions. For more insights … Read more